Alnylam Pharmaceuticals (ALNY) stock Forecast for 2022 – 2026

Alnylam Pharmaceuticals (ALNY) stock Forecast for 2022 – 2026

Last update: May 27, 2022 (06:32)

Sector: Healthcare

The share price of Alnylam Pharmaceuticals, Inc. (ALNY) now

What analysts predict: $238.73

52-week high/low: $236.8 / $117.58

50/200 Day Moving Average: $197.08 / $162.57

This figure corresponds to the average price over the previous 50/200 days. For Alnylam Pharmaceuticals stocks, the 50-day moving average is the support level today.

For Alnylam Pharmaceuticals stocks, the 200-day moving average is the support level today.

Are you interested in Alnylam Pharmaceuticals, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Alnylam Pharmaceuticals stock price in 2022, 2023, 2024, 2025, 2026. How much will one Alnylam Pharmaceuticals share be worth in 2022 - 2026?

When should I take profit in Alnylam Pharmaceuticals stock? When should I record a loss on Alnylam Pharmaceuticals stock? What are analysts' forecasts for Alnylam Pharmaceuticals stock? What is the future of Alnylam Pharmaceuticals stock?

We forecast Alnylam Pharmaceuticals stock performance using neural networks based on historical data on Alnylam Pharmaceuticals stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Alnylam Pharmaceuticals stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2022, 2023, 2024, 2025 and 2026)

The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Alnylam Pharmaceuticals shares. This happens once a day.





Historical and forecast chart of Alnylam Pharmaceuticals stock

The chart below shows the historical price of Alnylam Pharmaceuticals stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Alnylam Pharmaceuticals stock price can be found in the table below.

Long-term forecasts by years.

Alnylam Pharmaceuticals daily forecast for a month

Date Target Pes. Opt. Vol., %
May 29 129.75 127.62 130.42 2.19
May 30 130.32 128.56 131.00 1.90
May 31 129.31 128.20 130.75 1.99
Jun 01 125.94 123.72 127.12 2.75
Jun 02 128.40 125.73 129.43 2.95
Jun 03 127.80 126.04 129.49 2.74
Jun 04 127.27 125.68 129.52 3.05
Jun 05 125.65 123.95 127.51 2.87
Jun 06 127.77 126.67 129.33 2.10
Jun 07 128.93 126.32 131.21 3.88
Jun 08 130.47 129.12 133.09 3.07
Jun 09 133.09 131.87 133.95 1.57
Jun 10 134.40 132.27 135.69 2.59
Jun 11 133.81 132.07 135.58 2.66
Jun 12 133.63 131.27 135.96 3.57
Jun 13 137.11 135.11 138.21 2.30
Jun 14 136.00 133.17 137.81 3.48
Jun 15 135.75 134.55 136.85 1.70
Jun 16 135.61 132.93 137.59 3.50
Jun 17 133.50 132.80 135.48 2.01
Jun 18 134.96 132.67 137.20 3.41
Jun 19 136.71 134.79 139.16 3.24
Jun 20 139.87 137.65 141.51 2.80
Jun 21 141.58 138.90 142.83 2.84
Jun 22 140.88 138.80 143.52 3.40
Jun 23 140.92 138.72 141.73 2.17
Jun 24 142.31 139.98 144.53 3.25
Jun 25 141.94 139.80 142.68 2.06
Jun 26 142.98 140.52 145.43 3.49
Jun 27 141.82 139.46 143.41 2.83

Alnylam Pharmaceuticals Daily Price Targets


Alnylam Pharmaceuticals Stock Forecast 05-29-2022.

Forecast target price for 05-29-2022: $129.75. Negative dynamics for Alnylam Pharmaceuticals shares will prevail with possible volatility of 2.147%.

Pessimistic target level: 127.62

Optimistic target level: 130.42


Alnylam Pharmaceuticals Stock Forecast 05-30-2022.

Forecast target price for 05-30-2022: $130.32. Positive dynamics for Alnylam Pharmaceuticals shares will prevail with possible volatility of 1.863%.

Pessimistic target level: 128.56

Optimistic target level: 131.00


Alnylam Pharmaceuticals Stock Forecast 05-31-2022.

Forecast target price for 05-31-2022: $129.31. Negative dynamics for Alnylam Pharmaceuticals shares will prevail with possible volatility of 1.955%.

Pessimistic target level: 128.20

Optimistic target level: 130.75


Alnylam Pharmaceuticals Stock Forecast 06-01-2022.

Forecast target price for 06-01-2022: $125.94. Negative dynamics for Alnylam Pharmaceuticals shares will prevail with possible volatility of 2.679%.

Pessimistic target level: 123.72

Optimistic target level: 127.12


Alnylam Pharmaceuticals Stock Forecast 06-02-2022.

Forecast target price for 06-02-2022: $128.40. Positive dynamics for Alnylam Pharmaceuticals shares will prevail with possible volatility of 2.863%.

Pessimistic target level: 125.73

Optimistic target level: 129.43


Alnylam Pharmaceuticals Stock Forecast 06-03-2022.

Forecast target price for 06-03-2022: $127.80. Negative dynamics for Alnylam Pharmaceuticals shares will prevail with possible volatility of 2.669%.

Pessimistic target level: 126.04

Optimistic target level: 129.49


ALNY (ALNY) Monthly Stock Prediction for 2022

Month Target Pes. Opt. Vol., %
Oct. 214.76 196.57 224.45 12.42
Nov. 211.93 198.41 223.58 11.26
Dec. 220.78 213.98 236.81 9.64

Alnylam Pharmaceuticals forecast for this year


Alnylam Pharmaceuticals Stock Prediction for Oct 2022

An uptrend is forecast for this month with an optimal target price of $214.76. Pessimistic: $196.57. Optimistic: $224.45


Alnylam Pharmaceuticals Stock Prediction for Nov 2022

An downtrend is forecast for this month with an optimal target price of $211.925. Pessimistic: $198.41. Optimistic: $223.58


Alnylam Pharmaceuticals Stock Prediction for Dec 2022

An uptrend is forecast for this month with an optimal target price of $220.784. Pessimistic: $213.98. Optimistic: $236.81




Alnylam Pharmaceuticals (ALNY) Monthly Stock Prediction for 2023

Month Target Pes. Opt. Vol., %
Jan 217.63 202.07 223.61 9.64
Feb 207.33 192.51 224.89 14.40
Mar 225.81 215.87 238.72 9.57
Apr 220.34 214.28 234.64 8.68
May 217.19 204.05 228.66 10.76
Jun 220.54 206.47 236.30 12.63
Jul 212.53 202.24 224.92 10.08
Aug 213.93 204.52 224.29 8.81
Sep 196.28 187.00 206.22 9.32
Oct 192.61 184.14 200.88 8.33
Nov 208.29 197.07 216.54 8.99
Dec 202.11 190.99 218.56 12.61

Alnylam Pharmaceuticals (ALNY) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
Jan 191.88 177.32 199.90 11.30
Feb 190.82 178.23 199.01 10.44
Mar 200.90 190.51 214.38 11.13
Apr 201.78 196.90 209.55 6.04
May 205.56 194.70 216.41 10.03
Jun 208.95 191.94 225.73 14.97
Jul 197.69 186.60 202.04 7.64
Aug 203.77 191.89 210.50 8.84
Sep 201.98 194.87 213.54 8.74
Oct 202.43 191.74 217.79 11.96
Nov 209.77 192.47 224.77 14.37
Dec 218.77 208.18 236.82 12.09



Alnylam Pharmaceuticals (ALNY) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 219.25 206.95 228.42 9.40
Feb 221.43 207.30 229.95 9.85
Mar 219.72 207.88 226.73 8.31
Apr 221.17 206.09 228.71 9.89
May 240.39 224.79 260.75 13.79
Jun 241.18 221.29 252.06 12.21
Jul 229.24 223.70 235.30 4.93
Aug 240.84 227.86 257.27 11.43
Sep 261.77 253.71 270.41 6.18
Oct 254.00 241.43 272.72 11.47
Nov 262.66 240.99 277.68 13.21
Dec 262.37 243.61 278.25 12.45

Alnylam Pharmaceuticals (ALNY) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 240.44 228.54 251.28 9.05
Feb 237.26 228.39 249.01 8.28
Mar 241.44 220.72 248.34 11.12
Apr 253.66 237.19 271.23 12.55
May 271.51 254.19 281.07 9.56
Jun 272.41 249.04 290.69 14.33
Jul 285.89 267.03 303.82 12.11
Aug 284.95 273.98 307.21 10.82
Sep 293.41 267.59 317.30 15.66
Oct 312.78 299.70 336.17 10.85
Nov 328.95 321.35 347.04 7.40
Dec 340.53 312.44 350.27 10.80

Alnylam Pharmaceuticals information and performance

Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, is engaged in the discovery, development and commercialization of RNA interference (RNAi) therapeutics. The company’s line of investigated RNAi therapies focuses on genetic drugs, cardiovascular diseases, liver infections, and central nervous system (CNS) / eye diseases.

Alnylam Pharmaceuticals Address

675 WEST KENDALL STREET, HENRI A. TERMEER SQUARE, CAMBRIDGE, MA, US

Market Capitalization: 24 099 021 000 $

Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share.

EBITDA: -671 937 984 $

EBITDA is earnings before interest, income tax and depreciation of assets.

PE Ratio: None

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: -0.49

Price/earnings to growth

DPS: N/A

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: N/A

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: -7.49

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A

Quarterly Revenue Growth YOY: 0.019

Trailing PE: -

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: -

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 25.99

Enterprise Value (EV) /Revenue

EV To EBITDA: -31.4

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 120027000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A

Percent Insiders: N/A

Percent Institutions: N/A




Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.